4//SEC Filing
Fussell Stephen R 4
Accession 0001179110-19-002642
CIK 0000001800other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:08 PM ET
Size
10.8 KB
Accession
0001179110-19-002642
Insider Transaction Report
Form 4
Fussell Stephen R
Senior Vice President
Transactions
- Award
Common shares without par value
2019-02-22+26,350→ 187,402 total - Award
Option (right to buy)
2019-02-22+138,121→ 138,121 totalExercise: $75.90From: 2020-02-22Exp: 2029-02-21→ Common shares (138,121 underlying)
Holdings
- 1,683(indirect: By Trust)
Common shares without par value
- 53(indirect: By Spouse)
Common shares without par value
Footnotes (4)
- [F1]These shares represent performance-based restricted stock awards under the Abbott Laboratories 2017 Incentive Stock Program. The awards have a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 22, 2019.
- [F3]The reporting person disclaims beneficial ownership of all securities held by his spouse.
- [F4]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 46,040 on February 22, 2020, 46,040 on February 22, 2021, and 46,041 on February 22, 2022.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001327700
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:08 PM ET
- Size
- 10.8 KB